Table 3. A comparison between the five highest-ranked OA and non-OA journals according to SJR index. Impact factors were taken from 2016–2017 journal citation report (JCR 2017).
| OA status | Journals | Citation count | Scholarly output | Impact factor | Scopus coverage | Country |
|---|---|---|---|---|---|---|
| Non-OA | Ca-A Cancer Journal for Clinicians | 16,961 | 130 | 244.59 | 1950 | USA |
| Nature Reviews Cancer | 7,743 | 403 | 42.784 | 2001 | UK | |
| The Lancet Oncology | 18,794 | 1,815 | 36.42 | 2000 | UK | |
| Cancer Cell | 9,257 | 599 | 22.84 | 2002 | USA | |
| Journal of Clinical Oncology | 27,777 | 2,642 | 26.30 | 1983 | USA | |
| OA | Breast Cancer Research | 2,848 | 486 | 6.14 | 1999 | UK |
| Journal for ImmunoTherapy of Cancer | 1,281 | 219 | 8.37 | 2014 | UK | |
| Molecular Cancer | 4,074 | 566 | 7.78 | 2002 | UK | |
| Blood Cancer Journal | 1,240 | 334 | 8.13 | 2011 | USA | |
| Journal of Hematology and Oncology | 2,267 | 367 | 7.33 | 2008 | UK |
OA, open access; SJR, SCImago journal rank.